Optimization of the protocols for the use of contrast agents in PET/CT studies.

@article{Martnez2017OptimizationOT,
  title={Optimization of the protocols for the use of contrast agents in PET/CT studies.},
  author={L Pelegr{\'i} Mart{\'i}nez and Andres Alejandro Kohan and J L Vercher Conejero},
  journal={Radiologia},
  year={2017},
  volume={59 1},
  pages={
          64-74
        }
}
The introduction of PET/CT scanners in clinical practice in 1998 has improved care for oncologic patients throughout the clinical pathway, from the initial diagnosis of disease through the evaluation of the response to treatment to screening for possible recurrence. The CT component of a PET/CT study is used to correct the attenuation of PET studies; CT also provides anatomic information about the distribution of the radiotracer. CT is especially useful in situations where PET alone can lead to… CONTINUE READING